Clinical Trials Logo

Filter by:
NCT ID: NCT04762771 Terminated - Covid19 Clinical Trials

Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)

Colheart-19
Start date: December 23, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-label unblinded, randomized study to treat hospitalized covid-19 patients with colchicine plus current care (per institution treating physicians) vs. current care per institution treating physicians alone (the control arm)

NCT ID: NCT04762511 Terminated - Herpes Simplex Clinical Trials

A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years

Start date: March 2, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this first-time-in-human (FTiH) study is to assess the reactogenicity, safety and immunogenicity of four different dose levels of an experimental herpes simplex virus type 2 (HSV-2) vaccine, when administered intramuscularly (IM) on a 0, 2-month schedule to healthy participants aged 18-40 years.

NCT ID: NCT04762225 Terminated - Melanoma Clinical Trials

RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma

Start date: May 10, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of escalating doses of RPTR-168 as a monotherapy in patients with HPV-16 E6/E7 positive tumors (HNSCC, cervical) and melanoma.

NCT ID: NCT04762160 Terminated - Follicular Lymphoma Clinical Trials

SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma

Start date: December 15, 2020
Phase: Phase 2
Study type: Interventional

This study evaluates the safety and efficacy of combining the EZH2 inhibitor tazemetostat with rituximab in R/R FL subjects previously treated with at least 2 standard prior systemic treatment regimens where at least 1 anti-CD20-based regimen was used.

NCT ID: NCT04761679 Terminated - Pressure Injury Clinical Trials

Nasal Bridge Pressure Injury Prevention

Start date: March 23, 2021
Phase: N/A
Study type: Interventional

The primary goal of this study is to explore whether applying the Mepilex foam on the nasal bridge directly between the skin and the N95 mask will prevent nasal bridge pressure injury among nursing staff, secondary to long-term ( >8+ hours) wear time. The secondary goal is to evaluate if using the Mepilex maintains the seal of the mask.

NCT ID: NCT04761601 Terminated - Clinical trials for Advanced Solid Tumor

First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

Start date: March 3, 2021
Phase: Phase 1
Study type: Interventional

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of UCT-01-097 in patients with advanced solid tumors.

NCT ID: NCT04760938 Terminated - Anxiety Disorders Clinical Trials

Treating Adolescents With CBT and OBH

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine various behavioral, social, and emotional changes that result from engaging in an OBH and CBT treatment program designed for adolescents.

NCT ID: NCT04760054 Terminated - Cognitive Change Clinical Trials

Effects of a Complex, Partnered Martial Arts-based Intervention on Cognitive Function

HUBOD
Start date: March 24, 2021
Phase: N/A
Study type: Interventional

The investigators' study is designed to test whether brief exposure to a martial arts-based intervention (a coordinative, partnered training exercise known as "Hubod"), can improve cognitive function to a greater degree than aerobic exercise of a similar intensity.

NCT ID: NCT04759989 Terminated - Obesity Clinical Trials

Fluid Resuscitation in Septic Shock Patients With BMI Elevation

FRISSBE
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.

NCT ID: NCT04759872 Terminated - Insulin Resistance Clinical Trials

Insulin and Muscle Fat Metabolism

Start date: February 22, 2021
Phase: N/A
Study type: Interventional

Our objective in this study is to identify the extent to which insulin drives the accumulation of lipids in skeletal muscle of humans. We will test the hypothesis that 4-hours of mild hyperinsulinemia will result in significant muscle lipid accumulation and that such effects will be similar in lean and overweight/obese humans.